What's new

Human medicines European public assessment report (EPAR): Teriparatide Ascend, teriparatide, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Teriparatide Ascend, teriparatide, Status: Application withdrawn

May 26, 2025 - 14:55
 0
Human medicines European public assessment report (EPAR): Teriparatide Ascend, teriparatide, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Teriparatide Ascend, teriparatide, Status: Application withdrawn
Read More

Tags:

Previous Article

UK drops investigations against Symrise in fragrance cartel probe

Next Article

USAF Showcases Airpower with Dissimilar Bomber-Fighter ‘Freedom Formation’

Related Posts

Nitrosamine impurities: guidance for marketing authorisation holders

Nitrosamine impurities: guidance for marketing authoris...

May 28, 2025  0

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - December 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 December 2025, 11:00 (CET) to 18 December 2025, 12:00 (CET)

Questions and answers clinic on Product Management Serv...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Cubicin, daptomycin, Date of authorisation: 19/01/2006, Revision: 40, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0